ORAL FTORAFUR VERSUS INTRAVENOUS 5-FLUOROURACIL - A COMPARATIVE-STUDY IN PATIENTS WITH COLORECTAL-CANCER

被引:24
作者
ANDERSEN, E
PEDERSEN, H
机构
[1] FINSEN INST,DEPT ONCOL 1,DK-2100 COPENHAGEN O,DENMARK
[2] FINSEN INST,DEPT ONCOL 2,DK-2100 COPENHAGEN O,DENMARK
关键词
D O I
10.3109/02841868709113713
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:433 / 436
页数:4
相关论文
共 19 条
[1]  
AU JL, 1981, RECENT RESULTS CANCE, P100
[2]  
BEDEKIAN AY, 1983, AM J CLIN ONCOL, V6, P181
[3]  
BEDEKIAN AY, 1983, CANCER TREAT REP, V67, P81
[4]  
BENVENUTO JA, 1978, CANCER RES, V38, P3867
[5]  
BLOKHINA NG, 1972, CANCER-AM CANCER SOC, V30, P390, DOI 10.1002/1097-0142(197208)30:2<390::AID-CNCR2820300214>3.0.CO
[6]  
2-E
[7]  
DIASO RB, 1979, P AM ASS CANCER RES, V21, P401
[8]  
DINDOGRU A, 1980, P AM ASSOC CANC RES, V21, P167
[9]   A REVIEW OF THE UNITED-STATES CLINICAL-EXPERIENCE OF THE FLUOROPYRIMIDINE, FTORAFUR (NSC-148958) [J].
FRIEDMAN, MA ;
IGNOFFO, RJ .
CANCER TREATMENT REVIEWS, 1980, 7 (04) :205-213
[10]  
LU K, 1975, PHARMACOLOGIST, V17, P202